T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLL
126
DELISTED
PALL CORP
PLL
| $932M | 0.2% |
9,211,771
+636,621
| +7% | +$58.7M |
|
127
NRG Energy
NRG
$25.2B
| $930M | 0.2% |
34,504,115
-3,555,226
| -9% | -$105M |
|
|
128
Canadian Natural Resources
CNQ
$98.1B
| $930M | 0.2% |
62,287,583
+46,496,431
| +294% | +$759M |
|
129
Cigna
CI
$72.4B
| $926M | 0.2% |
8,993,879
+3,421,735
| +61% | +$337M |
|
130
Liberty Global Class C
LBTYK
$3.4B
| $912M | 0.19% |
23,334,837
-3,544,166
| -13% | -$129M |
|
131
Costco
COST
$419B
| $908M | 0.19% |
6,404,634
-763,425
| -11% | -$104M |
|
132
Johnson Controls International
JCI
$93.7B
| $907M | 0.19% |
17,917,282
+2,726,475
| +18% | +$133M |
|
133
AES
AES
$10.5B
| $901M | 0.19% |
65,414,003
+5,660,130
| +9% | +$77.3M |
|
134
Bristol-Myers Squibb
BMY
$130B
| $897M | 0.19% |
15,198,442
-261,710
| -2% | -$14.8M |
|
135
Nike
NKE
$61.3B
| $888M | 0.19% |
18,462,842
-66,272
| -0.4% | -$3.11M |
|
136
Trip.com Group
TCOM
$29.1B
| $881M | 0.19% |
38,746,792
-5,927,560
| -13% | -$155M |
|
137
Estee Lauder
EL
$31.8B
| $870M | 0.18% |
11,417,999
-177,874
| -2% | -$13.1M |
|
138
Las Vegas Sands
LVS
$29.6B
| $856M | 0.18% |
14,724,848
-9,776,824
| -40% | -$589M |
|
|
WBA
139
DELISTED
Walgreens Boots Alliance
WBA
| $853M | 0.18% |
11,199,667
+1,852,132
| +20% | +$124M |
|
140
Henry Schein
HSIC
$9.94B
| $850M | 0.18% |
15,917,194
-1,035,209
| -6% | -$51.5M |
|
141
Union Pacific
UNP
$174B
| $848M | 0.18% |
7,118,263
-166,123
| -2% | -$19.1M |
|
|
ALTR
142
DELISTED
Altera Corp
ALTR
| $842M | 0.18% |
22,803,530
-1,544,590
| -6% | -$54.6M |
|
143
Ross Stores
ROST
$80.8B
| $838M | 0.18% |
17,772,750
+12,106
| +0.1% | +$511K |
|
144
Ametek
AME
$58.8B
| $835M | 0.18% |
15,874,314
+7,106,960
| +81% | +$361M |
|
145
T-Mobile US
TMUS
$192B
| $832M | 0.18% |
30,876,937
+19,635,657
| +175% | +$543M |
|
146
Fidelity National Information Services
FIS
$22.1B
| $831M | 0.18% |
13,366,418
+4,833,398
| +57% | +$284M |
|
147
Fidelity National Financial
FNF
$12.8B
| $830M | 0.18% |
34,706,354
+468,521
| +1% | +$9.95M |
|
148
United Parcel Service
UPS
$88.8B
| $830M | 0.18% |
7,462,082
-210,862
| -3% | -$22.3M |
|
|
RAD
149
DELISTED
Rite Aid Corporation
RAD
| $828M | 0.18% |
5,507,918
+318,488
| +6% | +$35.4M |
|
|
AET
150
DELISTED
Aetna Inc
AET
| $817M | 0.17% |
9,199,453
+1,792,333
| +24% | +$150M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.